Stephens Inc. AR Grows Stake in CME Group Inc (CME)
Stephens Inc. AR grew its holdings in CME Group Inc (NASDAQ:CME) by 7.0% during the 4th quarter, Holdings Channel reports. The firm owned 8,676 shares of the financial services provider’s stock after buying an additional 567 shares during the period. Stephens Inc. AR’s holdings in CME Group were worth $1,267,000 at the end of the most recent reporting period.
Several other hedge funds have also added to or reduced their stakes in the company. Scotia Capital Inc. acquired a new stake in CME Group during the second quarter worth approximately $211,000. Koch Industries Inc. boosted its position in CME Group by 16,136.1% during the second quarter. Koch Industries Inc. now owns 278,612 shares of the financial services provider’s stock worth $276,000 after acquiring an additional 276,896 shares during the last quarter. Public Employees Retirement System of Ohio boosted its position in CME Group by 2.2% during the second quarter. Public Employees Retirement System of Ohio now owns 234,173 shares of the financial services provider’s stock worth $29,328,000 after acquiring an additional 4,983 shares during the last quarter. WINTON GROUP Ltd boosted its position in CME Group by 6.4% during the second quarter. WINTON GROUP Ltd now owns 66,331 shares of the financial services provider’s stock worth $8,307,000 after acquiring an additional 3,983 shares during the last quarter. Finally, Advisory Services Network LLC boosted its position in CME Group by 8,266.3% during the second quarter. Advisory Services Network LLC now owns 6,944 shares of the financial services provider’s stock worth $870,000 after acquiring an additional 6,861 shares during the last quarter. Institutional investors and hedge funds own 82.65% of the company’s stock.
In other news, Chairman Terrence A. Duffy sold 20,000 shares of the firm’s stock in a transaction on Tuesday, February 6th. The shares were sold at an average price of $151.66, for a total value of $3,033,200.00. Following the transaction, the chairman now owns 99,239 shares of the company’s stock, valued at approximately $15,050,586.74. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Sunil Cutinho sold 2,600 shares of the firm’s stock in a transaction on Friday, November 17th. The shares were sold at an average price of $139.57, for a total transaction of $362,882.00. Following the completion of the transaction, the insider now directly owns 22,301 shares in the company, valued at approximately $3,112,550.57. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 67,128 shares of company stock worth $10,086,157. 0.57% of the stock is currently owned by insiders.
CME Group (NASDAQ:CME) last posted its quarterly earnings results on Thursday, February 1st. The financial services provider reported $1.12 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.10 by $0.02. The company had revenue of $900.00 million for the quarter, compared to the consensus estimate of $886.85 million. CME Group had a net margin of 111.49% and a return on equity of 7.68%. CME Group’s revenue was down 1.4% on a year-over-year basis. During the same quarter last year, the firm posted $1.14 earnings per share. equities analysts expect that CME Group Inc will post 6.26 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Monday, March 26th. Shareholders of record on Friday, March 9th will be paid a dividend of $0.70 per share. The ex-dividend date is Thursday, March 8th. This represents a $2.80 dividend on an annualized basis and a yield of 1.79%. This is an increase from CME Group’s previous quarterly dividend of $0.66. CME Group’s dividend payout ratio (DPR) is currently 22.11%.
A number of analysts recently issued reports on the stock. BidaskClub upgraded shares of CME Group from a “buy” rating to a “strong-buy” rating in a research report on Saturday. Citigroup raised their target price on shares of CME Group from $138.00 to $155.00 and gave the stock a “buy” rating in a research report on Thursday, October 19th. Barclays raised their target price on shares of CME Group from $170.00 to $175.00 and gave the stock an “overweight” rating in a research report on Friday, February 2nd. Sandler O’Neill restated a “buy” rating and set a $175.00 target price on shares of CME Group in a research report on Friday, February 2nd. Finally, Bank of America raised their target price on shares of CME Group from $173.00 to $175.00 and gave the stock a “buy” rating in a research report on Friday, February 2nd. Three research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the stock. CME Group has a consensus rating of “Buy” and an average target price of $157.00.
TRADEMARK VIOLATION NOTICE: “Stephens Inc. AR Grows Stake in CME Group Inc (CME)” was originally reported by Watch List News and is owned by of Watch List News. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this piece can be viewed at https://www.watchlistnews.com/stephens-inc-ar-grows-stake-in-cme-group-inc-cme/1859340.html.
CME Group Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.